Patents by Inventor Haibo Han

Haibo Han has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODY AND ANTIGEN RECOGNIZING TUMOR-INITIATING CELLS AND USE THEREOF
    Publication number: 20200040097
    Abstract: Disclosed is a method for searching, identifying, or validating a marker CACNA2D1 of tumor-initiating cells. The method comprises a step of immunizing an animal using HEP-12 cells originating from a recurrent tumor and rich in originating cells. Also disclosed is a monoclonal antibody specially recognizing CACNA2D1 or antigen-binding fragments thereof, and the use thereof for treating or preventing tumors or diseases or conditions related to CACNA2D1.
    Type: Application
    Filed: January 3, 2019
    Publication date: February 6, 2020
    Applicant: Beijing Institute for Cancer Research
    Inventors: Zhiqian Zhang, Wei Zhao, Limin Wang, Haibo Han, Baocai Xing
  • Antibody and binding fragment recognizing CACNA2D1 and use thereof
    Patent number: 10174123
    Abstract: Disclosed is a method for searching, identifying, or validating a marker CACNA2D1 of tumor-initiating cells. The method comprises a step of immunizing an animal using HEP-12 cells originating from a recurrent tumor and rich in originating cells. Also disclosed is a monoclonal antibody specially recognizing CACNA2D1 or antigen-binding fragments thereof, and the use thereof for treating or preventing tumors or diseases or conditions related to CACNA2D1.
    Type: Grant
    Filed: February 22, 2012
    Date of Patent: January 8, 2019
    Assignee: Beijing Institute for Cancer Research
    Inventors: Zhiqian Zhang, Wei Zhao, Limin Wang, Haibo Han, Baocai Xing
  • ANTIBODY AND ANTIGEN RECOGNIZING TUMOR-INITIATING CELLS AND USE THEREOF
    Publication number: 20140044729
    Abstract: Disclosed is a method for searching, identifying, or validating a marker CACNA2D1 of tumor-initiating cells. The method comprises a step of immuninizing an animal using HEP-12 cells originating from a recurrent tumor and rich in originating cells. Also disclosed is a monoclonal antibody specially recognizing CACNA2D1 or antigen-binding fragments thereof, and the use thereof for treating or preventing tumors or diseases or conditions related to CACNA2D1.
    Type: Application
    Filed: February 22, 2012
    Publication date: February 13, 2014
    Applicant: BEIJING INSTITUTE FOR CANCER RESEARCH
    Inventors: Zhiqian Zhang, Wei Zhao, Limin Wang, Haibo Han, Baocai Xing